Workflow #3584

✓ Completed

Type: Benzinga Article

Started: December 05, 2025 at 9:23:30 PM

Completed: December 05, 2025 at 9:23:32 PM

Completed in 1s

Triggered by: ingestion

Job Pipeline

clean_raw_article

✓ completed

→

clean_markdown_article

✓ completed

→

analyze_article

✓ completed

→

link_article_to_stories

⊘ skipped

→

analyze_sentiment

✓ completed

clean_raw_article

✓ CompletedPending

River Jobs: 1

River Job #44808View LLM Log →

Definition: clean_raw_article →

clean_markdown_article

✓ CompletedPending

River Jobs: 1

River Job #44809View LLM Log →

Definition: clean_markdown_article →

analyze_article

✓ CompletedPending

River Jobs: 1

River Job #44810View LLM Log →

Definition: analyze_article →

link_article_to_stories

⊘ SkippedSkipped

analyze_sentiment

✓ CompletedPending

River Jobs: 1

River Job #44811View LLM Log →

Definition: analyze_sentiment →

Workflow Context

title:Johnson & Johnson Announces New Data From Investigational Cohort 4 Of Phase 2b SunRISe-1 Study Show Treatment With Gemcitabine Intravesical System Resulted In High One-Year DFS, PFS, And OS Rates In Patients With BCG-Unresponsive, High-Risk, Papillary-Only NMIBC

source:Benzinga

content:

article_id:5206 →

content_type:article